Conmed Q2 Adj EPS $0.83 Beats $0.79 Estimate, Sales $317.65M Beat $306.09M Estimate
Portfolio Pulse from saritha@benzinga.com
Conmed (NYSE:CNMD) reported Q2 earnings of $0.83 per share, beating the analyst consensus estimate of $0.79 by 5.06%. This is a 9.21% increase from the same period last year. The company also reported quarterly sales of $317.65 million, beating the analyst consensus estimate of $306.09 million by 3.78%. This is a 14.60% increase from the same period last year.
July 26, 2023 | 8:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Conmed's Q2 earnings and sales exceeded analyst estimates, indicating a strong financial performance. This could potentially lead to a positive impact on the company's stock price in the short term.
Conmed's earnings and sales for Q2 have surpassed analyst estimates, which is typically a positive signal for investors. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100